drug · small molecule
RNS-60
Phase 2updated 6mo agoby Revalesio Corp🔗 ChEMBL
Phase 2community read0 votes
🐶 often sniffed alongside
top 8- tagApproval1,230 co-mentions · 563 sources
- drugLACTATED RINGER'S IN PLASTIC CONTAINER440 co-mentions · 296 sources
- drugLACTATED RINGER'S AND DEXTROSE 5% IN PLASTIC CONTAINER376 co-mentions · 296 sources
- drugPOTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER318 co-mentions · 296 sources
- drugCALCIUM CHLORIDE 10%296 co-mentions · 296 sources
- companyFresenius Kabi USA LLC236 co-mentions · 149 sources
- tagRecall152 co-mentions · 79 sources
- drugPanheprin84 co-mentions · 42 sources
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 8 approved and 289 investigational indications.
indications
indications
ALS
all catalysts(0)
nothing on the calendar yet
News(10)
- Early Alert: Arrow International Removes Products Containing Spring Wire Guide ComponentsSpring Wire Guides containing hydrophilic coating may detach and release particles into the bloodstream, risking embolism.fda_medwatch · 9d ago
- WuXi Biologics, Fresenius partner ahead of biosimilar boomWuXi Biologics and German drugmaker Fresenius have reached one of the largest biosimilar deals to date ahead of what some in the industry have called an upcoming “golden decade” for such products. ...endpoints · 16d ago
- Robotics company Multiply Labs nets $75M; Isotope maker NorthStar gets up to $185MPlus, news about Roche’s Genentech and Fresenius Kabi. Multiply Labs collects $75M: The robotics biomanufacturing company’s Series B raise will be used to increase its capacity and headcount as it…endpoints · 1mo ago
- Viatris boosts pain drug portfolio with $1.7B buyout of PaciraThe deal hands Viatris two non-opioid pain treatments that booked nearly $700 million in 2025 but could soon lose patent protection. Viatris vowed to use its “intellectual property expertise” to su…biopharma_dive · 1mo ago
- Fresenius Kabi manufacturing plant hit with FDA warning letter after adverse eventsPatients had adverse events after receiving a Fresenius Kabi medicine that experienced manufacturing deviations.biospace · 1mo ago
- After GLP-1s, biosimilars are the new frontier in direct-to-employer plansFresenius Kabi will sell biosimilars directly to employers. To accomplish that, the drugmaker is working with Eversana-owned Waltz Health, which runs a marketplace that helps employers shop for bet…endpoints · 1mo ago
- Convenience Kit Correction: Becton Dickinson Issues Correction for Kits and Procedure Trays Containing Recalled Sodium Chloride AmpulesBD is correcting convenience kits and procedural trays containing recalled Huons Co. sodium chloride ampulesfda_medwatch · 1mo ago
- Par Health Issues Voluntary Nationwide Recall of Two Lots of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection Due to the Presence of Particulate MatterROCHESTER, MI– September 18, 2026 –Par Health is voluntarily recalling two lots of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection 400 mcg/100 mL (4 mcg/mL) to the hospital level. The product…fda_medwatch · 1mo ago
- Otsuka ICU Medical LLC Issues Voluntary Nationwide Recall of 0.9% Sodium Chloride Injection, USP Due To a Product Mix-up with 10 mEq Potassium Chloride InjectionOtsuka ICU Medical LLC is issuing a voluntary recall for one lot of 0.9% SODIUM CHLORIDE Injection, USP, 100mL single pack to the user level due to a potential mix-up. The affected lot of 0.9% SODI…fda_medwatch · 1mo ago
- Convenience Kit Correction: AVID Medical Issues Correction for Kits Containing Huons Sodium Chloride AmpulesAVID Medical is correcting convenience kits containing recalled Huons Co. sodium chloride ampules.fda_medwatch · 1mo ago
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that